1,172
Views
33
CrossRef citations to date
0
Altmetric
Original Research

Hypertension and Its Associated Factors Among Type 2 Diabetes Mellitus Patients at Debre Tabor General Hospital, Northwest Ethiopia

ORCID Icon & ORCID Icon
Pages 1621-1631 | Published online: 13 May 2020

References

  • Eren NK, Harman E, Dolek D, Levent F. Rate of blood pressure control and antihypertensive treatment approaches in diabetic patients with hypertension. Arch Turk Soc Cardiol. 2014;42(8):733–740. doi:10.5543/tkda.2014.53384
  • Emdin CA, KazemRahimi B, Neal TC, Callender T, Perkovic V, Patel A. Blood pressure lowering in type 2 diabetes a systematic review and meta-analysis. JAMA. 2015;313(6):603–615. doi:10.1001/jama.2014.18574
  • Chen G, Mcalister FA, Walker RL, Hemmelgarn BR, Campbell NRC, Commentary SE. Population science/epidemiology cardiovascular outcomes in Framingham participants the importance of blood pressure. Hypertension. 2011;57(5):891–897. doi:10.1161/HYPERTENSIONAHA.110.162446
  • Nouh F, Omar M, Younis M. Prevalence of hypertension among diabetic patients in Benghazi: a study of associated factors. Asian J Med Heal. 2017;6(4):1–11. doi:10.9734/AJMAH/2017/35830
  • Vargas-uricoechea H, Cáceres-acosta MF. Control of blood pressure and cardiovascular outcomes in type 2 diabetes. Open Med. 2018;13:304–323. doi:10.1515/med-2018-0048
  • International Diabetes Federation. Eighth Edition 2017. 2017. doi:10.1016/S0140-6736(16)31679-8
  • Ward JD, Manes C, Ionescu-tirgoviste C, Witte DR, Fuller JH. Vascular risk factors and diabetic neuropathy. New Engl J Med Orig. 2005;352(4):341–350. doi:10.1056/NEJMoa032782
  • Cohuet GS-B, Struijker-Boudier H. Mechanisms of target organ damage caused by hypertension: therapeutic potential. Pharmacol Ther. 2006;111(2006):81–98. doi:10.1016/j.pharmthera.2005.09.002
  • Forlemu AAMGASK, Menanga A, Ashuntantang G, Kingue S. Urinary protein excretion is associated with left ventricular hypertrophy in treatment- naïve hypertensive patients in an African hospital setting. Cardiorenal Med. 2013;3(3):57–62. doi:10.1159/000349938
  • Rodrigues JCL, Amadu AM, Dastidar AG, et al. ECG strain pattern in hypertension is associated with myocardial cellular expansion and diffuse interstitial fibrosis: a multi-parametric cardiac magnetic resonance study. Eur Hear J Cardiovasc Imaging. 2017;2017(18):441–450. doi:10.1093/ehjci/jew117
  • Siddiqui MA, Mittal PK, Brent P, et al. Secondary hypertension and complications: diagnosis and role of imaging. RadioGraphics. 2019;39(4):1036–1055. doi:10.1148/rg.2019180184
  • Esh H, Agabiti E, France MA, et al. 2018 ESC/ESH guidelines for the management of arterial hypertension the task force for the management of arterial hypertension of the European Society of Cardiology (ESC) and the European Society of Hypertension (ESH). Eur Hear J. 2018;2018(00):1–98. doi:10.1097/HJH
  • Nithish C, Prasad RB, Reddy MRRM. Estimation of risk factors for cardio vascular diseases in urban & semi-urban population: a prospective observational study. International J Med Heal Res. 2019;2019(5):84–86.
  • Cochran WG. Sampling techniques, 2nd edn. JBiometrische Zeitschrift. 1965;7(3):203.
  • Voulgari C, Papadogiannis D, Tentolouris N. Diabetic cardiomyopathy: from the pathophysiology of the cardiac myocytes to current diagnosis and management strategies. Vasc Health Risk Manag. 2010;6(1):883–903. doi:10.2147/VHRM.S11681
  • Thiruvoipati T. Peripheral artery disease in patients with diabetes: epidemiology, mechanisms, and outcomes. World J Diabetes. 2015;6(7):961. doi:10.4239/wjd.v6.i7.961
  • Zhou M, Wang A, Yu H. Link between insulin resistance and hypertension: what is the evidence from evolutionary biology? Diabetol Metab Syndr. 2014;6(12):1–8. doi:10.1186/1758-5996-6-12
  • Grillo A, Salvi L, Coruzzi P, Paolo Salv GP. Sodium intake and hypertension. Nutrients. 2019;11(1970):1–16. doi:10.3390/nu11091970
  • Unadike BC, Eregie A, Ohwovoriole AE. Prevalence of hypertension amongst persons with diabetes mellitus in Benin City, Nigeria. Niger J Clin Pract. 2011;14(3):300–302. doi:10.4103/1119-3077.86772
  • Mansour AA. Prevalence and control of hypertension in Iraqi diabetic patients: a prospective cohort study. Open Cardiovasc Med J. 2012;6(1):68–71. doi:10.2174/1874192401206010068
  • Williams B, Esh GM, Spiering W, et al. 2018 ESC/ESH guidelines for the management of arterial hypertension: the task force for the management of arterial hypertension of the European Society of Cardiology and the European Society of Hypertension. J Hypertension. 2018;36(10):1953–2041. doi:10.1093/eurheartj/ehy339
  • Benetos A, Davis AM, Michos ED, et al. Diabetes and hypertension: a position statement by the American Diabetes Association. Diabetes Care. 2017;40(9):1273–1284. doi:10.2337/dci17-0026
  • Owolabi EO, Ter GD, Adeniyi OV, Seekoe E. Social epidemiology of hypertension in Buffalo City Metropolitan Municipality (BCMM): cross-sectional study of determinants of prevalence, awareness, treatment and control among South African adults. BMJ Open. 2017;7(6):1–12. doi:10.1136/bmjopen-2016-014349
  • Kabakov E, Koffle M, Karen Tordjman CN. Prevalence of hypertension in type 2 diabetes mellitus: impact of the tightening definition of high blood pressure and association with confounding risk factors. J Cardiometabolic Syndr. 2006;1(2):95–101. doi:10.1111/j.1559-4564.2006.05513.x
  • Tadesse K, Amare H, Hailemariam T, Gebremariam T. Prevalence of hypertension among patients with type 2 diabetes mellitus and its socio demographic factors in Nigist Ellen Mohamed Memorial Hospital. J Diabetes Metab. 2018;9(1):4. doi:10.4172/2155-6156.1000792
  • Dedefo A, Galgalo A, Jarso G, Mohammed A. Prevalence of hypertension and its management pattern among type 2 diabetic patients attending, Adama Hospital Medical College, Adama. J Diabetes Metab. 2018;9(10):1–8. doi:10.4172/2155-6156.1000808
  • Alice YY. Canadian diabetes association clinical practice guidelines expert committee. Can J Diabetes. 2019;37(2013):1–3. doi:10.1016/j.jcjd.2013.01.009
  • Mariye T, Girmay A, Tasew H, Teklay G. Determinants of hypertension among diabetic patients in public hospitals of the Central Zone, Tigray, Ethiopia 2018: unmatched case- control study. Pan Afr Med J. 2019;8688:1–12. doi:10.11604/pamj.2019.33.100.17094
  • Berraho M, Achhab YE, Benslimane A, Rhazi KEL, Chikr M. Open access. Pan Afr Med J. 2012;8688(1–9).
  • Mengesha AY. Hypertension and related risk factors in type 2 diabetes mellitus (DM) patients in Gaborone City Council (GCC) clinics, Gaborone. Afr Health Sci. 2007;7(4):244–245.
  • Giday A, Wolde M, Yihdego D. Hypertension, obesity and central obesity in diabetics and non diabetics in Southern Ethiopia. Ethiop J Heal Dev. 2010;24(2):2–4.
  • American Diabetes Association. Classification and diagnosis of diabetes: standards of medical care in diabetes d 2019. Diabetes Care. 2019;42(1):13–28. doi: 10.2337/dc19-S002.
  • Noh J, Chang Y, Park M, Kwon YD, Ryu S. Self-rated health and the risk of incident type 2 diabetes mellitus: A cohort study. Sci Rep Open. 2019;9(3697):1–8. doi:10.1038/s41598-019-40090-y
  • Nuttall FQ. Body mass index. Nutr Res. 2015;50(3):117–128. doi:10.1097/NT.0000000000000092
  • Solomon T, Tamiru S, Alemseged F. Risk factors for cardiovascular diseases among diabetic patients in southwest Ethiopia. Ethiop J Health Sci. 2010;20(2):121–128. doi:10.4314/ejhs.v20i2.69438
  • Waly EH, Hamed MS. Hypertension and dyslipidemia among type II diabetic patients and related risk factors and complications methods. Egypt J Community Med. 2018;36(1):31–43.
  • Tatsumi Y, Ohkubo T. Hypertension with diabetes mellitus: signi fi cance from an epidemiological perspective for Japanese. Hypertens Res. 2017;(March):1–12. doi:10.1038/hr.2017.67
  • Mubarak FM, Froelicher ES, Jaddou HY, Ajlouni M. original article. Ann Saudi Med. 2008;28(5):346–351. doi:10.5144/0256-4947.2008.346
  • Demarco VG, Aroor AR, Sowers JR. The pathophysiology of hypertension in patients with obesity. Endocrinology. 2014;10(6):1–13. doi:10.1038/nrendo.2014.44
  • Humayun A, Shah AS, Sultana R. Relation of hypertension with body mass index and age in male and female population of Peshawar, Pakistan. J Ayub Med Coll Abbottabad. 2009;21(3):63–65.
  • Asresahegn H, Tadesse F, Beyene E. Prevalence and associated factors of hypertension among adults in Ethiopia: a community based cross ‑ sectional study. BMC Res Notes. 2017;2017(10:629):1–8. doi:10.1186/s13104-017-2966-1
  • Hall JE, Do Carmo JM, da Silva AA, Wang Z, Hall ME. Obesity-induced hypertension: interaction of neurohumoral and renal mechanisms. Circ Res. 2016;116(6):991–1006. doi:10.1161/CIRCRESAHA.116.305697.OBESITY-INDUCED
  • Liew SJ, Lee JT, Tan CS, Huat C, Koh G, Müller-Riemenschneider F. Sociodemographic factors in relation to hypertension prevalence, awareness, treatment and control in a multi-ethnic Asian population: a cross- sectional study. BMJ Open. 2019;9(5):1–10. doi:10.1136/bmjopen-2018-025869
  • Khanam R, Ahmed S, Rahman S, et al. Prevalence and factors associated with hypertension among adults in rural Sylhet district of Bangladesh: a cross- sectional study. BMJ Open. 2019;9(10):1–9. doi:10.1136/bmjopen-2018-026722
  • Head T, Daunert S, Goldschmidt-Clermont PJ. The aging risk and atherosclerosis: a fresh look at arterial homeostasis. Front Genet. 2017;8(12):1–11. doi:10.3389/fgene.2017.00216
  • National Institute of Aging. Aging Hearts and Arteries a Scientific Quest. 2005.
  • Kohn JC, Lampi MC, Reinhart-king CA. Age-related vascular stiffening: causes and consequences. Front Genet. 2015;6(3):1–18. doi:10.3389/fgene.2015.00112
  • Tesfaye F, Nawi NG, Van MH, et al. Association between body mass index and blood pressure across three populations in Africa and Asia. J Hum Hypertens. 2007;21(1):28–37. doi:10.1038/sj.jhh.1002104
  • Agyemang C. Rural and urban differences in blood pressure and hypertension in Ghana, West Africa. J R Inst Public Heal. 2006;120(6):525–533. doi:10.1016/j.puhe.2006.02.002
  • Taylor BC, Wilt TJ, Welch HG. Impact of diastolic and systolic blood pressure on mortality: implications for the definition of normal. J Gen Intern Med. 2011;26(7):685–690. doi:10.1007/s11606-011-1660-6
  • Van de Poel E, O’Donnell O, Van Doorslaer E. Urbanization and the spread of diseases of affluence in China. Econ Hum Biol. 2009;7(2):200–216. doi:10.1016/j.ehb.2009.05.004
  • Gong P, Liang S, Carlton EJ, et al. Urbanisation and health in China. Lancet. 2012;379(9818):843–852. doi:10.1016/S0140-6736(11)61878-3
  • Patel TP, Rawal K, Bagchi AK, et al. Insulin resistance: an additional risk factor in the pathogenesis of cardiovascular disease in type 2 diabetes. Heart Fail Rev. 2016;21(1):11–23. doi:10.1007/s10741-015-9515-6
  • Gates PE, Strain WD, Shore AC. Human endothelial function and microvascular ageing. Exp Physiol. 2009;94(3):311–316. doi:10.1113/expphysiol.2008.043349
  • Ames MK, Atkins CE, Pitt B. The renin-angiotensin-aldosterone system and its suppression. J Vet Intern Med. 2019;33(2):363–382. doi:10.1111/jvim.15454
  • Heianza Y, Arase Y, Kodama S, et al. Fasting glucose and HbA1c levels as risk factors for the development of hypertension in Japanese individuals: toranomon hospital health management center study 16. J Hum Hypertens. 2014;29(4):254–259. DOI:10.1038/jhh.2014.77
  • Ray KK, Rao S, Seshasai K, et al. Eff ect of intensive control of glucose on cardiovascular outcomes and death in patients with diabetes mellitus: a meta-analysis of randomised controlled trials. Lancet. 2009;373(9677):1765–1772. doi:10.1016/S0140-6736(09)60697-8
  • Stettler C, Allemann S, Ju P. Glycemic control and macrovascular disease in types 1 and 2 diabetes mellitus: meta-analysis of randomized trials. Am Heart J. 2006;151(1):27–38. doi:10.1016/j.ahj.2005.09.015
  • Katakami N. Mechanism of development of atherosclerosis and cardiovascular disease in diabetes mellitus. J Atheroscler Thromb. 2018;25(1):27–39. doi:10.5551/jat.RV17014
  • Wolfsdorf JI, Glaser N, Agus M, et al. ISPAD clinical practice consensus guidelines ISPAD clinical practice consensus guidelines 2018: diabetic ketoacidosis and the hyperglycemic hyperosmolar state. Pediatr Diabetes. 2018;19(10):155–177. doi:10.1111/pedi.12701
  • Wu J, Li T, Song X, Sun W, Zhang Y, Liu Y. Prevalence and distribution of hypertension and related risk factors in Jilin Province, China 2015: a cross- sectional study. BMJ Open. 2018;8(3):1–10. doi:10.1136/bmjopen-2017-020126
  • Khader Y, Batieha A, Jaddou H, et al. Hypertension in Jordan: prevalence, awareness, control, and its associated factors. Int J Hypertens. 2019;2019:1–9. doi:10.1155/2019/3210617
  • Andreas FA, Flouris D, Constantine I, Vardavas GS, Metsios AM. Tsatsakis and yiannis koutedakis. Am J Physiol Lung Cell Mol Physiol. 2010;298(1):L3–L2. doi:10.1152/ajplung.00215.2009
  • Lee J, Cooke JP. The role of nicotine in the pathogenesis of atherosclerosis. Atherosclerosis. 2013;215(2):281–283. doi:10.1016/j.atherosclerosis.2011.01.003.The
  • Birben E, Sahiner UM, Sackesen C, Erzurum S, Kalayci O. Oxidative stress and antioxidant defense. World Allergy Organ J. 2012;5(1):9–19. doi:10.1097/WOX.0b013e3182439613
  • Dhungana RR, Pandey AR, Bista B, Joshi S, Devkota S. Prevalence and associated factors of hypertension: a community-based cross-sectional study in municipalities of Kathmandu, Nepal. Int J Hypertens. 2016;2016:1–11. doi:10.1155/2016/1656938
  • Papathanasiou G, Zerva E, Zacharis I, et al. Association of high blood pressure with body mass index, smoking and physical activity in healthy young adults. Open Cardiovasc Med J. 2015;9(1):5–17. doi:10.2174/1874192401509010005
  • Olack B, Wabwire-mangen F, Smeeth L, Montgomery JM, Kiwanuka N, Breiman RF. Risk factors of hypertension among adults aged 35 – 64 years living in an urban slum Nairobi, Kenya. BMC Public Health. 2015;2015(1251):1–9. doi:10.1186/s12889-015-2610-8
  • Wang J, Sun W, Wells GA, et al. Differences in prevalence of hypertension and associated risk factors in urban and rural residents of the northeastern region of the People ’ s Republic of China: a cross-sectional study. Plos One. 2018;13(4):1–14.